Serologic Status According Severe Acute Respiratory Syndrome Coronavirus 2 in Patients After Orthotopic Heart Transplantation동소 심장 이식 후 환자의 중증 급성 호흡기 증후군 코로나 바이러스 2에 따른 혈청학적 상태Article Published on 2022-05-012022-09-12 Journal: Transplantation proceedings [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] antibodies antibody binding antibody unit coronavirus 2 Course COVID-19 COVID-19 infection determine doses effective Effectiveness Elecsy had no heart humoral Infection infections interquartile range investigated marker median time men mRNA vaccine organ Orthotopic Patient patients Population respiratory SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 spike protein serologic single dose Spike protein status susceptibility the patient transplantation vaccination Vaccine Viral vector vaccine virus were assessed women [DOI] 10.1016/j.transproceed.2022.02.044 PMC 바로가기 [Article Type] Article
Detection of antibodies against SARS-CoV-2 both in plasma pools for fractionation and in commercial intravenous immunoglobulins produced from plasma collected in Italy during the pandemic분획을 위한 혈장 풀과 전염병 기간 동안 이탈리아에서 수집된 혈장에서 생산된 상업용 정맥 면역글로불린 모두에서 SARS-CoV-2에 대한 항체 검출Article Published on 2022-05-012022-09-11 Journal: Blood transfusion = Trasfusione del sangue [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법, [키워드] Amplification assay anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibodies antibody authority collected Concentration Control detection determine Elecsy Grifol Grifols Immunoglobulin immunoglobulins intravenous Intravenous immunoglobulin investigated Italian Italian region Italy lombardy material nucleocapsid protein official pandemic plasma positive produced qualitative detection Quantitative reactive reactivity Receptor binding domain Release Roche SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 spike tested [DOI] 10.2450/2021.0055-21 PMC 바로가기 [Article Type] Article
The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine RecipientsmRNA 백신 수혜자의 상업용 SARS-CoV-2 혈청학적 및 유사형 중화 분석에 대한 백신 유형 및 SARS-CoV-2 계통의 효과Article Published on 2022-04-272022-09-11 Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] affected Alpha anti-S anti-S antibody Anti-SARS-CoV-2 S Anti-spike anti-spike antibodies anti-spike antibody Antibody testing approach association Beta Beta variant BNT162b2 CDC Characteristics Cohort collected Concentration correlated correlation COVID-19 infection Day determine difficulty Effect Elecsy enrolled epidemiological evaluated Gamma healthy Immunity immunity after vaccination immunogenicity individuals Interpretation interval Level Lower marker mRNA mRNA vaccine mRNA vaccines mRNA-1273 mRNA-1273 vaccine Neutralization assay Neutralizing activity neutralizing antibody neutralizing titers pseudotype receiving recipient recipients recommendation recruited Roche SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 variant SARS-CoV-2 variants serologic serologic assay serologic assays serology serum significantly higher Support surrogate Type vaccinated individual vaccination Vaccine variable variant were measured wild-type WT strain [DOI] 10.1128/spectrum.00211-22 PMC 바로가기 [Article Type] Article
The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells비활성화된 SARS-CoV-2 백신(CoronaVac) 및/또는 SARS-CoV-2 감염이 항체 수준, 형질모세포, 수명이 긴 형질 세포 및 자연 살해 세포에 의한 IFN-γ 방출에 미치는 영향Article Published on 2022-04-202022-09-11 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] anti-S anti-SARS-CoV-2 spike protein anti-spike antibody antibody Antibody Response B cell CD138 CD19 CD27 Cell CoronaVac COVID-19 detectable dose Elecsy elicited ELISA kit evaluated flow cytometry four groups Germinal center group groups HCW HCWs healthcare worker Healthcare workers IAV IFN-gamma IFN-γ immunization inactivated Inactivated vaccine interferon gamma İstanbul Killer cell long-lived plasma cell long-lived plasma cells Lymph node lymph nodes median memory B cell memory B cells Migration natural infection natural killer natural killer cell no difference not differ patients percentage phenotype Plasma cells plasmablast plasmablasts qPCR RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine significantly higher significantly lower Spike protein study groups Test the antibody response the study group Turkey uninfected Vaccine Version virion was performed were measured Whole virion inactivated vaccine. [DOI] 10.1016/j.vaccine.2022.03.001 PMC 바로가기 [Article Type] Article
Discrepant serological findings in SARS‐CoV‐2 PCR‐negative hospitalized patients with fever and acute respiratory symptoms during the pandemicResearch Article Published on 2022-03-122022-10-04 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] acute respiratory illness acute respiratory symptom acute respiratory syndrome antibody assays B‐cell Bacterial infection Bacterial infections Cohort collected convalescent coronavirus COVID‐19 COVID‐19 Diagnosis Elecsy ELISA epitope Fever hospital Hospital admission Hospital stay hospitalized patient immunosorbent Infection initial Interpretation interquartile range Isolation male Nasopharyngeal swab Neutralizing pandemic Patient patients PCR performed plasma polymerase chain positive question raise recruited S protein SARS‐CoV‐2 serological serological test serology Singapore tested [DOI] 10.1002/jmv.27656 PMC 바로가기 [Article Type] Research Article
Seroprevalence of COVID-19 infection among vaccine naïve population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study남인도 농촌 지역에서 두 번째 급증(2020년 6월) 후 백신 경험이 없는 인구 사이에서 COVID-19 감염의 혈청 유병률: 지역 사회 기반 횡단면 연구Research Article Published on 2022-03-102022-09-12 Journal: PLoS ONE [Category] MERS, SARS, 진단, [키워드] 95% CI adjusted antibody conducted COVID-19 COVID-19 infection cross-sectional cross-sectional study determine District effort Elecsy family member FIVE Health herd immunity house IFR IgG IgM Immunity Infection naïve objective past population density positive COVID-19 presence of antibody Prevalence Protein Randomly Rate RBD Receptor-binding domain recruited relief Result Roche Rural health SARS CoV SARS CoV-2 SARS-CoV-2 self Seropositivity Seroprevalence Serosurvey significantly South south India Symptom tested the receptor-binding domain thought Vaccine [DOI] 10.1371/journal.pone.0265236 PMC 바로가기 [Article Type] Research Article
Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India감염, 초기 COVID-19 예방 접종 중 농촌 지역의 SARS-CoV-2로 인한 사례: 인도 동부 농촌 코호트의 혈청 조사 연구 결과Article Published on 2022-03-032022-09-12 Journal: Epidemiology and Infection [Category] MERS, SARS, 진단, [키워드] age antibody block blood sample carried categories Cluster Cohort coronavirus Coverage COVID COVID-19 COVID-19 case COVID-19 vaccination disease Elecsy eligible Epidemiology female group immunoassay India Infection information initial management Model Probability provide Rural area SARS-CoV-2 SARS-CoV-2 antibody selected Sero-survey Serosurvey socio-demographic Surveillance susceptible unit vaccination Vaccine virus was tested [DOI] 10.1017/S0950268822000346 PMC 바로가기 [Article Type] Article
Evaluation of antibody response after COVID-19 vaccination of healthcare workers의료진의 코로나19 예방접종 후 항체반응 평가Article Published on 2022-03-012022-09-11 Journal: Journal of medical virology [Category] MERS, SARS, 진단, 치료법, [키워드] addition age antibody antibody levels Antibody Response antibody response against Antibody titer Antibody titers BMI BMI values body mass body mass index CoronaVac COVID-19 COVID-19 vaccination develop dose effective Elecsy Elecsys evaluated examined Factor female Gender HCW healthcare healthcare worker Healthcare workers immune response Immunity Inactivated vaccine individuals infected with COVID-19 interquartile range IQR male median age nucleocapsid protein obese participant Participants participated postvaccination RBD RBD protein Receptor binding Receptor binding domain Receptor-binding domain SARS-CoV-2 SARS-CoV-2 spike protein second dose second dose of vaccine Seropositivity Smokers smoking Spike protein the receptor-binding domain the SARS-CoV-2 U/mL Vaccine Volunteer volunteers was determined was measured [DOI] 10.1002/jmv.27420 PMC 바로가기 [Article Type] Article
Performance evaluation of Elecsys SARS-CoV-2 Antigen immunoassay for diagnostic of COVID-19코로나19 진단을 위한 Elecsys SARS-CoV-2 항원 면역분석의 성능 평가Article Published on 2022-03-012022-09-11 Journal: Journal of medical virology [Category] SARS, 치료기술, [키워드] 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 aims alternative Antigen antigen detection antigen tests Chain Reaction complement coronavirus COVID-19 cross Cross reactivity cross-reactivity Cycle threshold value diagnostic Elecsy Elecsys evaluate HKU1 identify immunoassay individual Infection Influenza Influenza virus Nasopharyngeal swab nasopharyngeal swabs Negative predictive value NPV OC43 other respiratory virus Other respiratory viruses parainfluenza virus performance point of care polymerase chain reaction positive PPV Predictive value Randomly ranged reduce reference test respiratory viruses reverse transcription Reverse transcription-polymerase chain reaction rhinovirus Roche Diagnostics RT-PCR RT-PCR testing SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigen tests SARS-CoV-2 transmission selected sensitivity severe acute respiratory syndrome Coronavirus specificity STAT Symptoms [DOI] 10.1002/jmv.27412 PMC 바로가기 [Article Type] Article
Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population백신 접종이 우세한 집단에서 SARS-CoV-2 감염 감지에 대한 다중 혈청학적 분석의 성능 평가Observation Published on 2022-02-232022-09-10 Journal: Microbiology Spectrum [Category] MERS, 진단, 치료법, [키워드] Antibody detection AUC value AUC values calculated Canada Cohort coronavirus COVID-19 COVID-19 infection COVID-19 infections cutoff value defined detection Elecsy Evidence evidence of excluded group highest identify IgG individual individuals Infection investigated Meso Scale Discovery MSD nucleocapsid Panel paramedics Participants PCR test performance Population positive SARS-CoV-2 PCR positive SARS-CoV-2 PCR test positive serology postvaccination prospective cohort required Roche sample collection SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 seroprevalence sensitivities sensitivity Sensitivity and specificity serology serum sample serum samples significantly significantly higher Specificities specificity subgroup subgroups test performance threshold vaccinated individuals vaccination Vaccination Status [DOI] 10.1128/spectrum.01454-21 PMC 바로가기 [Article Type] Observation